参考文献/References:
[1] J.Y. Ro, G.A. Staerkel, A.G. Ayala, Cytologic and histologic features of superficial bladder cancer [J]. Urol ClinNorthAm.1992,19(3):435-453.
[2] Whitson J, Berry A, Carroll P, et al. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy [J]. BJU Int, 2009, 104(3):336-339.
[3] Mian C, LoddeM, Comploj E, et al.Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer[J]. J Clin Pathol, 2006, 59(9): 984-987.
[4] BlaveriE,BrewerJL,RoydasguptaR,etal.Bladdercancer stage and outcome by array-based comparative genomic hybridization [J]. Clin Cancer Res, 2005, 11 (19 Pt 1): 7012-7022.
[5] Mian C, Lodde M, Comploj E, et al. Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer[J]. J Clin Pathol, 2006, 59(9):984-987.
[6]孙其鹏 ,庞俊 ,李辽源 ,等.荧光原位杂交技术在前列腺癌诊断中的临床应用 [J/CD].中华腔镜泌尿外科杂志：电子版,2010,4(1):54-57.
[7] Stephen BE, DavidRB, Carolyn CC. AJCC cancer staging handbook[J].AnnOncol,2009(4):678-679.
[8] Trotti A. AJCC Cancer Staging Handbook [J]. Ann Oncol,2009(4): 678-679.
[9]葛永超 ,吴书一 ,冯金顺 ,等.荧光原位杂交技术检测尿液脱落上皮细胞染色体畸变对膀胱癌的诊断价值 [J].中国实用医刊,2011,38(1):4-6.
[10]黄洁夫 ,湛海伦 ,杨飞 ,等.初次 TURBt术后病理分期低估原因的分析及处理策略 ,中华泌尿外科杂志,2012,33 (6):434-438.
[11] Karnwal A, Venegas R, Shuch B, et al. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer [J]. Can J Urol, 2010, 17(2): 5077-5081.
[12] Simonetti S, Russo R, Ciancia G, et al. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17[J]. Int J Surg Pathol, 2009, 17(3): 198-205.
[13] Houskova L, Zemanova Z, Babjuk M, et al. Molecular cytogenetic characterization and diagnostics of bladder cancer[J]. Neoplasma, 2007, 54(6): 511-516.
[14] Matsuyama H, Ikemoto K, Eguchi S, et al. Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscleinvasive bladder cancer (NIMBC)[J]. BJU Int, 2014, 113 (4): 662-667.
[15] Todenh觟fer T, Hennenlotter J, Tews V, et al. Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma [J]. Urol Oncol, 2013, 31 (7): 1148-1154.
相似文献/References:
[1]何娅娣,李辽源,潘志恒,等.前列腺干细胞抗原在膀胱尿路上皮癌组织中的表达及其临床意义[J].中华腔镜泌尿外科杂志(电子版),2011,(04):322.
HE Ya-di,LI Liao-yuan,PAN Zhi-heng,et al.Expression of PSCA protein in human bladder urothelial cancer and its clinical significance[J].,2011,(05):322.
[2]袁贺佳,吴吉涛,门昌平,等.后腹腔镜联合经尿道电切镜术后继发膀胱癌的危险因素分析[J].中华腔镜泌尿外科杂志(电子版),2016,10(04):226.[doi:10.3877/cma.j.issn.1674-3253.2016.04.003
]
Yuan Hejia,Wu Jitao,Men Changping,et al.Risk factors of secondary bladder cancer following retroperitoneal laparoscopic radical nephroureterectomy with resectoscopic excision of bladder cuff[J].,2016,10(05):226.[doi:10.3877/cma.j.issn.1674-3253.2016.04.003
]